Document Detail


The combined effect of ultrasound exposure and cisplatin on human ovarian carcinoma cells A2780.
MedLine Citation:
PMID:  18647549     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This article deals with an in vitro study of the effect of cisplatin and low intensity ultrasound exposure on the viability of human ovarial carcinoma cells A2780. The effect on the viability of 103 cell experimental group samples under the influence of separate and combined cisplatin and ultrasound far field exposure was studied. Viable cells in individual experimental groups were followed at time intervals of 0, 24, 48 and 72 hours following treatment. Another objective of the study was to investigate the effect of the experimental protocol on the combined effect of cisplatin and ultrasound exposure. The effect of the concurrent application of cisplatin and ultrasound exposure was compared with that in which cisplatin was added to the cell suspension after ultrasound exposure. The results of this work confirmed the cytotoxicity of cisplatin and possible stimulation of cancer cells by low intensity ultrasound. However, it was found that ultrasound exposure enhances the action of cisplatin on the viability of A2780 cells and that the effect is dependent on the experimental protocol. In this case the concurrent application of cisplatin and ultrasound was found to be more effective (P < 0.05).
Authors:
V Bernard; J Skorpíková; V Mornstein
Related Documents :
2454689 - Leukemic cell maturation: phenotypic variability and oncogene expression in hl60 cells:...
20187799 - Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enh...
6734569 - Cadmium uptake and metabolism in cultured cells.
19417139 - Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel prot...
19564079 - Recurrence cancer stem cells--made by cell fusion?
10938459 - Involvement of differential metallothionein expression in free radical sensitivity of r...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Folia biologica     Volume:  54     ISSN:  0015-5500     ISO Abbreviation:  Folia Biol. (Praha)     Publication Date:  2008  
Date Detail:
Created Date:  2008-07-23     Completed Date:  2008-09-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0234640     Medline TA:  Folia Biol (Praha)     Country:  Czech Republic    
Other Details:
Languages:  eng     Pagination:  97-101     Citation Subset:  IM    
Affiliation:
Department of Biophysics, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology*
Cell Line, Tumor
Cell Survival
Cisplatin / pharmacology*
Combined Modality Therapy
Female
Humans
Ovarian Neoplasms / metabolism,  pathology,  therapy*
Ultrasonic Therapy*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 15663-27-1/Cisplatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Frequency of representative single nucleotide polymorphisms associated with inflammatory bowel disea...
Next Document:  Lack of association of GSTT1, GSTM1, GSTO1, GSTP1 and CYP1A1 polymorphisms for susceptibility and ou...